1969
DOI: 10.1021/bi00840a045
|View full text |Cite
|
Sign up to set email alerts
|

Adrenal gland steroid C-21 cytochrome P-450 reductase

Abstract: The adrenal gland mitochondrial cytochrome P-450 reductase system (adrenal flavoprotein and adrenodoxin) is shown in this investigation to enhance steroid 21 hydroxylation in carefully prepared microsomal suspensions and acetone powder extracts. Examination of the reductase components separately reveals that the enhancement can be accounted for on the basis of the flavoprotein moiety alone.This implicates flavoprotein as an electron carrier in steroid 21 hydroxylation. While it seems likely that the mitochondr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

1970
1970
1980
1980

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(4 citation statements)
references
References 13 publications
0
4
0
Order By: Relevance
“…The adrenocortical mitochondrial ferredoxin was first reported by Omura et al (1965) and Kimura & Suzuki (1965), who proposed that this iron-sulfur protein component and an FAD-containing flavoprotein constituted an NADPH-dependent cytochrome P-450 reductase complex active in the 11/3-hydroxylation of deoxycorticosterone. Both adrenodoxin2 and adrenodoxin reductase have since been well characterized (Kimura & Suzuki, 1967;Suhara et al, 1972;Nakamura & Otsuka, 1966;Sweat et al, 1969).…”
mentioning
confidence: 99%
“…The adrenocortical mitochondrial ferredoxin was first reported by Omura et al (1965) and Kimura & Suzuki (1965), who proposed that this iron-sulfur protein component and an FAD-containing flavoprotein constituted an NADPH-dependent cytochrome P-450 reductase complex active in the 11/3-hydroxylation of deoxycorticosterone. Both adrenodoxin2 and adrenodoxin reductase have since been well characterized (Kimura & Suzuki, 1967;Suhara et al, 1972;Nakamura & Otsuka, 1966;Sweat et al, 1969).…”
mentioning
confidence: 99%
“…It is, however, generally accepted that a protein containing nonheme-iron and acid-labile sulphur does not participate in the hepatic microsomal hydroxylations of steroids and other substrates and indeed such proteins are probably absent in the liver [see 136]. A similar situation is believed to occur in adrenocortical microsomal steroid hydroxylations [178,281,312]. Adrenodoxin-like proteins are thought, however, to participate in steroidogenic hydroxylations by the mitochondria of the placenta, testis and corpus luteum of the ovary [136,176,278], It has been confirmed that the testis and corpus luteum ISPs can substitute for adrenodoxin in a deoxy corticosterone 11 ß-hydroxylating activity assay while corresponding prepara tions from liver, and Euglena and spinach ferredoxins, Pseudomonas rubredoxin and Pseudomonas putidaredoxin are inactive [136].…”
Section: L) Reduction Of Heme Proteins and Participation In Mixed-funmentioning
confidence: 99%
“…Recently, two different kinds ofmitochondrialP-450 cytochromes, catalyzing the cholesterol side-chain cleavage (P-450scc) and the steroid 11/3-hydroxylation (P-4501U3) have been highly purified from bovine adrenal cortex [1][2][3]. Investigations on the reaction mechanism of cytochrome P-450 in adrenal endoplasmic reticulum have been carried out using a microsomal particle or its extract [4][5][6][7][8][9][10][11][12][13]. However, so far as we know, no isolation of cytochrome P-450 from the microsomes has been achieved.…”
Section: Introductionmentioning
confidence: 99%